Assessment of troponin's role as a surveillance biomarker for immune checkpoint inhibitor cardiac toxicity and subsequent cardiovascular risk stratification.
Key Takeaways
- Although the reported incidence of ICI-associated myocarditis is relatively low
- Elevated troponin concentrations may reflect subclinical myocardial inflammation
- All-cause mortality has not been systematically established